Mayo Clinic - MN
Welcome,         Profile    Billing    Logout  
 4 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adjei, Alex A
MC1821, NCT04396535: Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer

Terminated
2
10
US
Bintrafusp Alfa, Anti-PDL1/TGFb Trap MSB0011359C, M7824, MSB0011359C, Docetaxel, Docecad, RP56976, Taxotere, Taxotere Injection Concentrate
Mayo Clinic, National Cancer Institute (NCI)
Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8
12/23
12/23
NCT03647163: Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Recruiting
1/2
70
US
VSV-IFNβ-NIS, Voyager-V1, VSV, VSV2, Pembrolizumab, ipilimumab + nivolumab
Vyriad, Inc., Mayo Clinic
Solid Tumor, Non Small Cell Lung Cancer, Neuroendocrine Carcinoma
12/24
12/24
RAMP 203, NCT05074810: Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients

Recruiting
1/2
153
Europe, US
avutometinib and sotorasib, AMG 510, LUMAKRAS™, VS-6766, avutometinib and sotorasib and defactinib, VS-6063
Verastem, Inc., Amgen
Non Small Cell Lung Cancer, KRAS Activating Mutation
09/25
04/27
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Terminated
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
06/24
KB-0742-1001, NCT04718675: A Study of KB-0742 in Participants with Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Recruiting
1/2
280
Europe, US
KB-0742
Kronos Bio
Relapsed Solid Tumors, Refractory Solid Tumors, Non-Hodgkin Lymphoma, HGSOC, Platinum Resistant High Grade Serous Ovarian Cancer
12/25
12/25
TRIO-049, NCT05103683: First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Recruiting
1
90
US
TORL-1-23
TORL Biotherapeutics, LLC, Translational Research in Oncology
Advanced Solid Tumor, Ovarian Cancer, Endometrial Cancer, NSCLC
11/24
11/25
NCT01896804: Calcitriol in Preventing Lung Cancer in High-Risk Patients

Recruiting
N/A
40
US
Calcitriol, 1,25(OH)2-D3, 1,25-Dihydroxycholecalciferol, Calcijex, Rocaltrol, Laboratory Biomarker Analysis, Pharmacological Study
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Angiogenic Squamous Dysplasia, Bronchial Intraepithelial Neoplasia, Squamous Metaplasia
12/17
 
Ihrke, Megan
FOENIX-MBC2 TAS-120-201, NCT04024436: A Study of TAS-120 in Patients With Metastatic Breast Cancer

Active, not recruiting
2
168
Europe, Canada, US
Futibatinib, TAS-120, Futibatinib plus Fulvestrant
Taiho Oncology, Inc.
Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification
05/23
10/24

Download Options